Skyline - OmicsDI

Show results for

Proteomics (1032)
Unknown (409)
Metabolomics (64)
Genomics (8)
Other (1)

Organisms

Schizosaccharomyces pombe (961)
Sinorhizobium meliloti BL225C (961)
Sus scrofa domesticus (961)
Saccharomyces cerevisiae (961)
Staphylococcus aureus (961)
Rattus norvegicus (961)
Escherichia coli (961)
Methylohalobius crimeensis 10Ki (961)
Homo sapiens (961)
Shigella flexneri (961)
Allexis (961)
Shigella (961)
Zea mays (961)
Meleagris gallopavo (961)
Medicago truncatula (961)
Listeria monocytogenes (961)
Homo sapiens (21)
Mus musculus (10)
Saccharomyces cerevisiae (8)
Bos taurus (5)
Escherichia coli (3)
Clostridium ljungdahlii DSM 13528 (2)
cellular organisms (2)
Saccharomyces cerevisiae S288C (1)
Eimeria tenella (1)
Montipora capitata (1)
Gasterosteus aculeatus (1)
Oryctolagus cuniculus (1)
Sus scrofa (1)
Gallus gallus (1)

Organisms

Homo sapiens (2)
Trichormus azollae HNT15244 (1)

Repository

pride (961)
MetaboLights (60)
MassIVE (34)
PanoramaPublic (19)
jPOST (13)
ENA (8)
iProX (6)
GNPS (4)

Tissue

Cell culture (150)
Blood plasma (61)
Brain (58)
Epithelial cell (50)
Liver (40)
Blood serum (36)
Permanent cell line cell (23)
Kidney (22)
Blood (21)
Plant cell (19)
Blood cell (19)
Lung (17)
B cell (15)
Embryonic stem cell (14)
Whole body (14)
Leaf (14)
Fibroblast (14)
Cerebrospinal fluid (13)
Heart (12)
Hepatocyte (12)
Skin (11)
Colon (11)
Embryo (10)
T cell (10)
Tooth enamel (9)
Melanocyte (8)
Macrophage (8)
Cell suspension culture (8)
HeLa cell (8)
Spleen (8)

Disease

Disease free (30)
Colon cancer (22)
Breast cancer (21)
Alzheimer's disease (14)
Acute leukemia (13)
COVID-19 (12)
Parkinson's disease (11)
Pancreatic cancer (7)
Malignant neoplasm of ovary (7)
Type 2 diabetes mellitus (6)
Tuberculosis (5)
Severe acute respiratory syndrome (4)
Pancreatic ductal adenocarcinoma (4)
Lung cancer (4)
Chronic myeloid leukemia (4)
Cervix carcinoma (4)
Brain cancer (4)
Lewy body dementia (3)
Non-small cell lung carcinoma (3)
Lung adenocarcinoma (3)
Lymphoma (3)
Metabolic dysfunction-associated steatotic liver disease (3)
Melanoma (3)
Cardiovascular system disease (3)
Atherosclerosis (3)
Influenza (3)
Brain glioma (2)
Myotonic dystrophy type 1 (2)
Pick's disease (2)
Corticobasal degeneration syndrome (2)

Technology Type

Mass Spectrometry (961)
Shotgun proteomics (397)
SRM/MRM (339)
Bottom-up proteomics (157)
Data-dependent acquisition (93)
SWATH MS (90)
Affinity purification coupled with mass spectrometry proteomics (87)
Data-independent acquisition (59)
Gel-based experiment (48)
Mass spectrometry (38)
Chemical cross-linking coupled with mass spectrometry proteomics (24)
Top-down proteomics (20)
Mass spectrometry assay (19)
All-ion fragmentation (14)
Affinity proteomics (5)
Immunopeptidomics (5)
MSE (5)
HDMSE (5)
NMR spectroscopy (4)
DiaPASEF (4)
Mass spectrometry imaging (3)
PAcIFIC (2)
Glycoproteomics (2)
RNA mass spectrometry (2)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (23)
Liquid Chromatography MS - negative - reverse phase (16)
Liquid Chromatography MS - alternating - reverse phase (9)
TSQ Quantiva (6)
TripleTOF 5600 (5)
Liquid Chromatography MS - positive - reverse-phase (5)
LTQ Orbitrap Velos (4)
Bruker (4)
Liquid Chromatography MS - alternating - hilic (4)
6495C Triple Quadrupole LC/MS (3)
Q Exactive Plus (3)
Orbitrap Exploris 480 (3)
Liquid Chromatography MS - alternating - reverse-phase (3)
Liquid Chromatography MS - negative - reverse-phase (3)
Liquid Chromatography MS - positive - hilic (3)
6560 Q-TOF LC/MS (2)
Velos Plus (2)
Orbitrap Fusion ETD (2)
TripleTOF 6600 (2)
Orbitrap Eclipse (2)
Orbitrap Fusion (2)
TimsTOF Pro 2 (2)
Q Exactive (2)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (2)
Gas Chromatography MS - positive (2)
Q Exactive|1001911 (1)
Xevo TQ-XS (1)
Orbitrap Astral (1)
Orbitrap Exploris 240 (1)
Orbitrap Fusion Lumos (1)

Publication Date

2025 (159)
2022 (143)
2024 (140)
2026 (125)
2020 (119)
2023 (116)
2021 (105)
2019 (56)
2018 (52)
2017 (40)
2016 (21)
2015 (12)
2014 (5)

CHEBI ID

CHEBI:16750 (13)
CHEBI:15428 (13)
CHEBI:16335 (13)
CHEBI:16704 (13)
CHEBI:17562 (10)
CHEBI:24898 (10)
CHEBI:25017 (10)
CHEBI:16020 (10)
CHEBI:17596 (10)
CHEBI:26271 (9)
CHEBI:18186 (8)
CHEBI:16811 (8)
CHEBI:15741 (8)
CHEBI:28044 (8)
CHEBI:16865 (8)
CHEBI:15891 (8)
CHEBI:16449 (8)
CHEBI:29016 (8)
CHEBI:16027 (8)
CHEBI:16737 (8)
CHEBI:30769 (8)
CHEBI:20794 (7)
CHEBI:17822 (7)
CHEBI:22660 (7)
CHEBI:28300 (7)
CHEBI:17802 (7)
CHEBI:16977 (7)
CHEBI:6650 (7)
CHEBI:16857 (7)
CHEBI:78320 (7)

Metabolite Name

1-methyladenosine (7)
Isoleucine (7)
7-methylguanosine (6)
Uridine (6)
Guanosine (6)
Tyrosine (6)
Creatinine (6)
2'-O-methyluridine (5)
3-methylcytidine (5)
5-methylcytidine (5)
2'-O-methylguanosine (5)
Leucine (5)
2'-O-methylcytidine (5)
Inosine (5)
Cytidine (5)
12-HETE (5)
13-HODE (5)
15-HETE (5)
Glycine (5)
Valine (5)
Adenosine (5)
Cytidine (5)
Uridine (5)
Creatine (5)
Tryptophan (5)
AA (4)
DHA (4)
1-methylpseudouridine (4)
TXB2 (4)
Pipecolinic acid (4)

First Public Date

2024 (3)
2013 (3)
2023 (1)
2010 (1)

Modification

N6 (15)
4x(15)N labeled L-arginine (11)
N6-dimethyl-L-lysine (11)
2x(15)N labeled L-lysine (9)
4 (3)
1x(15)N labeled L-leucine (1)
4-dinitrophenyl modified residue (1)
3x(2)H labeled N6-acetyl-L-lysine (1)
4x(2)H labeled dimethylated residue (1)
4-tetrahydrothiazine-3-carboxylic acid (1)

Release Date

2022 (36)
2023 (35)
2025 (33)
2024 (32)
2015 (31)
2021 (30)
2019 (30)
2018 (27)
2020 (26)
2017 (24)
2016 (22)
2012 (19)
2014 (18)
2013 (13)
2011 (12)
2010 (9)
2026 (5)
2008 (2)
2005 (2)
2009 (1)
2007 (1)
2004 (1)

Lab affiliation

Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA. Systems Biology Institute, Yale University, New Haven, CT 06516, USA (6)
Baylor College of Medicine (6)
Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA (5)
Utrecht University (5)
Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland Faculty of Science, University of Zurich, Zurich, Switzerland (4)
Head of Laboratory of Neuro-Oncology, Neurology, Clinical & Cancer Proteomics (4)
Moffitt Cancer Center (4)
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA (4)
Head of the Curie Institute Mass Spectrometry Platform (4)
University Hospital Cologne (4)
Functional proteomics group; Molecular Biomedicine department; CIB-CSIC (3)
State Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, China. (3)
Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, Bochum, Germany (3)
Department of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, USA. Systems Biology Institute, Yale University, New Haven, CT 06516, USA (3)
Chair of Molecular Biology Institute of Cellular and Molecular Biology Estonia (3)
Mendel University in Brno (3)
Mendel Centre for Plant Genomics and Proteomics, Central European Institute of Technology, Masaryk University, Brno, Czech Republic (3)
University of Washington, Department of Genome Sciences (3)
JGU University Mainz (3)
Proteomics Core Facility and Research Group Proteomics, CEITEC-MU, Masaryk University, Brno, Czech Republic (3)
Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, California 92521, United States (3)
Department of Bioactive and Functional Food Chemistry, Institute of Applied Biosciences, Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany (2)
Centre for Genomic Regulation (CRG), Barcelona, Spain (2)
Head of Scientific Archeology Unit, Weizmann Institute of Science (2)
Carnegie Mass Spectrometry Facility, Carnegie Institution for Science at Stanford (2)
Infection and Immunity Program, Biomedicine Discovery Institute & Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia (2)
Institute of Biochemistry (2)
Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Copenhagen, Denmark. (2)
Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland Faculty of Science, University of Zürich, Zürich, Switzerland (2)
VIB-UGent Center for Medical Biotechnology UGent Department of Biomolecular Medicine Technologiepark-Zwijnaarde 75 B9052 Gent Belgium (2)

1514 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets